ACTT-EU/UK trial finds remdesivir speeds up COVID-19 recovery
Tribute to Lynda Harper
Tribute to Gita Ramjee and Emmanuel Harding
Adaptive COVID-19 Treatment Trial recruits first patient
The Adaptive COVID-19 Treatment Trial in EU & UK (ACTT-EU/UK), which is testing treatments for COVID-19, recruited its first patient on 31 March. The trial, which is taking place in around 75 hospitals around the world, will initially test the drug remdesivir. Remdesivir is an antiviral drug that was developed to treat Ebola and Marburg virus infections. In the ACTT-EU/UK ...
MRC CTU at UCL response to COVID-19 pandemic